nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—PDE3A—cGMP effects—PDE2A—rheumatoid arthritis	0.00655	0.146	CbGpPWpGaD
Anagrelide—PDE3A—Nitric oxide stimulates guanylate cyclase—PDE2A—rheumatoid arthritis	0.00521	0.116	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—PDE2A—rheumatoid arthritis	0.00203	0.0452	CbGpPWpGaD
Anagrelide—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—rheumatoid arthritis	0.00143	0.0318	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—PDE2A—rheumatoid arthritis	0.0014	0.0312	CbGpPWpGaD
Anagrelide—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS3—rheumatoid arthritis	0.00115	0.0255	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—CD244—rheumatoid arthritis	0.00104	0.0233	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—CD2—rheumatoid arthritis	0.000791	0.0176	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—C1QBP—rheumatoid arthritis	0.000673	0.015	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—CD58—rheumatoid arthritis	0.000673	0.015	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—PTGES—rheumatoid arthritis	0.000613	0.0137	CbGpPWpGaD
Anagrelide—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000593	0.000621	CcSEcCtD
Anagrelide—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000592	0.00062	CcSEcCtD
Anagrelide—Convulsion—Dexamethasone—rheumatoid arthritis	0.000591	0.000619	CcSEcCtD
Anagrelide—Convulsion—Betamethasone—rheumatoid arthritis	0.000591	0.000619	CcSEcCtD
Anagrelide—Insomnia—Hydrocortisone—rheumatoid arthritis	0.00059	0.000617	CcSEcCtD
Anagrelide—Hypertension—Dexamethasone—rheumatoid arthritis	0.000589	0.000617	CcSEcCtD
Anagrelide—Hypertension—Betamethasone—rheumatoid arthritis	0.000589	0.000617	CcSEcCtD
Anagrelide—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000585	0.000613	CcSEcCtD
Anagrelide—Urticaria—Cyclosporine—rheumatoid arthritis	0.000583	0.00061	CcSEcCtD
Anagrelide—Myalgia—Betamethasone—rheumatoid arthritis	0.000581	0.000608	CcSEcCtD
Anagrelide—Myalgia—Dexamethasone—rheumatoid arthritis	0.000581	0.000608	CcSEcCtD
Anagrelide—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.00058	0.000607	CcSEcCtD
Anagrelide—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.00058	0.000607	CcSEcCtD
Anagrelide—Discomfort—Betamethasone—rheumatoid arthritis	0.000574	0.000601	CcSEcCtD
Anagrelide—Discomfort—Dexamethasone—rheumatoid arthritis	0.000574	0.000601	CcSEcCtD
Anagrelide—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000574	0.000601	CcSEcCtD
Anagrelide—Haemoglobin—Methotrexate—rheumatoid arthritis	0.000574	0.0006	CcSEcCtD
Anagrelide—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000572	0.000599	CcSEcCtD
Anagrelide—PDE3A—Hemostasis—KIF5A—rheumatoid arthritis	0.000572	0.0127	CbGpPWpGaD
Anagrelide—Pain—Prednisolone—rheumatoid arthritis	0.000571	0.000598	CcSEcCtD
Anagrelide—Hepatitis—Methotrexate—rheumatoid arthritis	0.000571	0.000597	CcSEcCtD
Anagrelide—Haemorrhage—Methotrexate—rheumatoid arthritis	0.000571	0.000597	CcSEcCtD
Anagrelide—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000567	0.000593	CcSEcCtD
Anagrelide—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000566	0.000593	CcSEcCtD
Anagrelide—Nausea—Leflunomide—rheumatoid arthritis	0.000565	0.000591	CcSEcCtD
Anagrelide—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000564	0.00059	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000563	0.000589	CcSEcCtD
Anagrelide—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000562	0.000589	CcSEcCtD
Anagrelide—Vision blurred—Prednisone—rheumatoid arthritis	0.00056	0.000586	CcSEcCtD
Anagrelide—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000559	0.000586	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000559	0.000586	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000558	0.000584	CcSEcCtD
Anagrelide—Pain—Hydrocortisone—rheumatoid arthritis	0.000558	0.000584	CcSEcCtD
Anagrelide—Oedema—Betamethasone—rheumatoid arthritis	0.000557	0.000583	CcSEcCtD
Anagrelide—Oedema—Dexamethasone—rheumatoid arthritis	0.000557	0.000583	CcSEcCtD
Anagrelide—Insomnia—Triamcinolone—rheumatoid arthritis	0.000555	0.000581	CcSEcCtD
Anagrelide—PDE3A—Platelet homeostasis—NOS2—rheumatoid arthritis	0.000555	0.0124	CbGpPWpGaD
Anagrelide—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000554	0.00058	CcSEcCtD
Anagrelide—Infection—Dexamethasone—rheumatoid arthritis	0.000553	0.000579	CcSEcCtD
Anagrelide—Infection—Betamethasone—rheumatoid arthritis	0.000553	0.000579	CcSEcCtD
Anagrelide—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000551	0.000577	CcSEcCtD
Anagrelide—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000551	0.000577	CcSEcCtD
Anagrelide—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.00055	0.000576	CcSEcCtD
Anagrelide—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.00055	0.000576	CcSEcCtD
Anagrelide—Visual impairment—Methotrexate—rheumatoid arthritis	0.00055	0.000576	CcSEcCtD
Anagrelide—Anaemia—Prednisone—rheumatoid arthritis	0.000549	0.000575	CcSEcCtD
Anagrelide—PDE3A—Hemostasis—RAD51B—rheumatoid arthritis	0.000548	0.0122	CbGpPWpGaD
Anagrelide—Shock—Dexamethasone—rheumatoid arthritis	0.000548	0.000574	CcSEcCtD
Anagrelide—Shock—Betamethasone—rheumatoid arthritis	0.000548	0.000574	CcSEcCtD
Anagrelide—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000547	0.000573	CcSEcCtD
Anagrelide—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000546	0.000572	CcSEcCtD
Anagrelide—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000546	0.000572	CcSEcCtD
Anagrelide—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000545	0.000571	CcSEcCtD
Anagrelide—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000545	0.000571	CcSEcCtD
Anagrelide—Tachycardia—Betamethasone—rheumatoid arthritis	0.000544	0.000569	CcSEcCtD
Anagrelide—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000544	0.000569	CcSEcCtD
Anagrelide—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.00054	0.000566	CcSEcCtD
Anagrelide—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000539	0.000565	CcSEcCtD
Anagrelide—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000538	0.000564	CcSEcCtD
Anagrelide—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000538	0.000564	CcSEcCtD
Anagrelide—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000537	0.000563	CcSEcCtD
Anagrelide—Malaise—Prednisone—rheumatoid arthritis	0.000536	0.000561	CcSEcCtD
Anagrelide—Eye disorder—Methotrexate—rheumatoid arthritis	0.000533	0.000558	CcSEcCtD
Anagrelide—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000533	0.000558	CcSEcCtD
Anagrelide—Syncope—Prednisone—rheumatoid arthritis	0.000533	0.000558	CcSEcCtD
Anagrelide—Tinnitus—Methotrexate—rheumatoid arthritis	0.000532	0.000557	CcSEcCtD
Anagrelide—Anorexia—Dexamethasone—rheumatoid arthritis	0.000531	0.000556	CcSEcCtD
Anagrelide—Anorexia—Betamethasone—rheumatoid arthritis	0.000531	0.000556	CcSEcCtD
Anagrelide—Urticaria—Prednisolone—rheumatoid arthritis	0.00053	0.000555	CcSEcCtD
Anagrelide—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.00053	0.000554	CcSEcCtD
Anagrelide—Fatigue—Triamcinolone—rheumatoid arthritis	0.000529	0.000554	CcSEcCtD
Anagrelide—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000528	0.000553	CcSEcCtD
Anagrelide—Asthenia—Cyclosporine—rheumatoid arthritis	0.000526	0.000551	CcSEcCtD
Anagrelide—Pain—Triamcinolone—rheumatoid arthritis	0.000525	0.00055	CcSEcCtD
Anagrelide—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000522	0.000547	CcSEcCtD
Anagrelide—Hypotension—Dexamethasone—rheumatoid arthritis	0.000521	0.000545	CcSEcCtD
Anagrelide—Hypotension—Betamethasone—rheumatoid arthritis	0.000521	0.000545	CcSEcCtD
Anagrelide—Pruritus—Cyclosporine—rheumatoid arthritis	0.000519	0.000543	CcSEcCtD
Anagrelide—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000518	0.000542	CcSEcCtD
Anagrelide—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000515	0.00054	CcSEcCtD
Anagrelide—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000515	0.00054	CcSEcCtD
Anagrelide—Convulsion—Prednisone—rheumatoid arthritis	0.000515	0.000539	CcSEcCtD
Anagrelide—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000514	0.000538	CcSEcCtD
Anagrelide—Hypertension—Prednisone—rheumatoid arthritis	0.000513	0.000537	CcSEcCtD
Anagrelide—Chills—Methotrexate—rheumatoid arthritis	0.000512	0.000536	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000507	0.000531	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000507	0.000531	CcSEcCtD
Anagrelide—Arthralgia—Prednisone—rheumatoid arthritis	0.000506	0.00053	CcSEcCtD
Anagrelide—Myalgia—Prednisone—rheumatoid arthritis	0.000506	0.00053	CcSEcCtD
Anagrelide—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000506	0.00053	CcSEcCtD
Anagrelide—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000505	0.000528	CcSEcCtD
Anagrelide—Alopecia—Methotrexate—rheumatoid arthritis	0.000504	0.000528	CcSEcCtD
Anagrelide—Insomnia—Betamethasone—rheumatoid arthritis	0.000504	0.000527	CcSEcCtD
Anagrelide—Insomnia—Dexamethasone—rheumatoid arthritis	0.000504	0.000527	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000503	0.000526	CcSEcCtD
Anagrelide—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000502	0.000526	CcSEcCtD
Anagrelide—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000501	0.000524	CcSEcCtD
Anagrelide—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.0005	0.000524	CcSEcCtD
Anagrelide—Paraesthesia—Betamethasone—rheumatoid arthritis	0.0005	0.000524	CcSEcCtD
Anagrelide—Discomfort—Prednisone—rheumatoid arthritis	0.0005	0.000523	CcSEcCtD
Anagrelide—Malnutrition—Methotrexate—rheumatoid arthritis	0.000497	0.00052	CcSEcCtD
Anagrelide—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.00049	0.000513	CcSEcCtD
Anagrelide—Dyspepsia—Betamethasone—rheumatoid arthritis	0.00049	0.000513	CcSEcCtD
Anagrelide—Urticaria—Triamcinolone—rheumatoid arthritis	0.000488	0.000511	CcSEcCtD
Anagrelide—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000487	0.000509	CcSEcCtD
Anagrelide—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000485	0.000508	CcSEcCtD
Anagrelide—Dizziness—Cyclosporine—rheumatoid arthritis	0.000485	0.000508	CcSEcCtD
Anagrelide—Oedema—Prednisone—rheumatoid arthritis	0.000485	0.000508	CcSEcCtD
Anagrelide—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000484	0.000507	CcSEcCtD
Anagrelide—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000484	0.000507	CcSEcCtD
Anagrelide—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000484	0.000507	CcSEcCtD
Anagrelide—Infection—Prednisone—rheumatoid arthritis	0.000482	0.000505	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000481	0.000503	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000481	0.000503	CcSEcCtD
Anagrelide—Back pain—Methotrexate—rheumatoid arthritis	0.000481	0.000503	CcSEcCtD
Anagrelide—Fatigue—Dexamethasone—rheumatoid arthritis	0.00048	0.000503	CcSEcCtD
Anagrelide—Fatigue—Betamethasone—rheumatoid arthritis	0.00048	0.000503	CcSEcCtD
Anagrelide—Shock—Prednisone—rheumatoid arthritis	0.000477	0.0005	CcSEcCtD
Anagrelide—Pain—Betamethasone—rheumatoid arthritis	0.000476	0.000499	CcSEcCtD
Anagrelide—Pain—Dexamethasone—rheumatoid arthritis	0.000476	0.000499	CcSEcCtD
Anagrelide—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000476	0.000498	CcSEcCtD
Anagrelide—Tachycardia—Prednisone—rheumatoid arthritis	0.000473	0.000496	CcSEcCtD
Anagrelide—Skin disorder—Prednisone—rheumatoid arthritis	0.000471	0.000493	CcSEcCtD
Anagrelide—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000469	0.000491	CcSEcCtD
Anagrelide—Vision blurred—Methotrexate—rheumatoid arthritis	0.000468	0.00049	CcSEcCtD
Anagrelide—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000468	0.00049	CcSEcCtD
Anagrelide—Vomiting—Cyclosporine—rheumatoid arthritis	0.000466	0.000488	CcSEcCtD
Anagrelide—Rash—Cyclosporine—rheumatoid arthritis	0.000463	0.000484	CcSEcCtD
Anagrelide—Anorexia—Prednisone—rheumatoid arthritis	0.000462	0.000484	CcSEcCtD
Anagrelide—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000462	0.000484	CcSEcCtD
Anagrelide—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000461	0.000483	CcSEcCtD
Anagrelide—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000461	0.000483	CcSEcCtD
Anagrelide—Headache—Cyclosporine—rheumatoid arthritis	0.00046	0.000481	CcSEcCtD
Anagrelide—Anaemia—Methotrexate—rheumatoid arthritis	0.000459	0.000481	CcSEcCtD
Anagrelide—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000459	0.000481	CcSEcCtD
Anagrelide—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000459	0.000481	CcSEcCtD
Anagrelide—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000455	0.000477	CcSEcCtD
Anagrelide—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000455	0.000477	CcSEcCtD
Anagrelide—PDE3A—Hemostasis—PDE2A—rheumatoid arthritis	0.000454	0.0101	CbGpPWpGaD
Anagrelide—Malaise—Methotrexate—rheumatoid arthritis	0.000448	0.000469	CcSEcCtD
Anagrelide—PDE3A—Platelet homeostasis—NOS3—rheumatoid arthritis	0.000446	0.00995	CbGpPWpGaD
Anagrelide—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000446	0.000467	CcSEcCtD
Anagrelide—Urticaria—Dexamethasone—rheumatoid arthritis	0.000443	0.000463	CcSEcCtD
Anagrelide—Urticaria—Betamethasone—rheumatoid arthritis	0.000443	0.000463	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000442	0.000463	CcSEcCtD
Anagrelide—Dizziness—Prednisolone—rheumatoid arthritis	0.000441	0.000462	CcSEcCtD
Anagrelide—Asthenia—Triamcinolone—rheumatoid arthritis	0.00044	0.000461	CcSEcCtD
Anagrelide—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.00044	0.000461	CcSEcCtD
Anagrelide—Body temperature increased—Betamethasone—rheumatoid arthritis	0.00044	0.000461	CcSEcCtD
Anagrelide—Abdominal pain—Betamethasone—rheumatoid arthritis	0.00044	0.000461	CcSEcCtD
Anagrelide—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.00044	0.000461	CcSEcCtD
Anagrelide—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000439	0.00046	CcSEcCtD
Anagrelide—Insomnia—Prednisone—rheumatoid arthritis	0.000439	0.000459	CcSEcCtD
Anagrelide—Nausea—Cyclosporine—rheumatoid arthritis	0.000436	0.000456	CcSEcCtD
Anagrelide—Paraesthesia—Prednisone—rheumatoid arthritis	0.000436	0.000456	CcSEcCtD
Anagrelide—Pruritus—Triamcinolone—rheumatoid arthritis	0.000434	0.000455	CcSEcCtD
Anagrelide—Cough—Methotrexate—rheumatoid arthritis	0.000433	0.000454	CcSEcCtD
Anagrelide—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000433	0.000454	CcSEcCtD
Anagrelide—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000431	0.000451	CcSEcCtD
Anagrelide—Convulsion—Methotrexate—rheumatoid arthritis	0.00043	0.000451	CcSEcCtD
Anagrelide—Dyspepsia—Prednisone—rheumatoid arthritis	0.000427	0.000447	CcSEcCtD
Anagrelide—Myalgia—Methotrexate—rheumatoid arthritis	0.000423	0.000443	CcSEcCtD
Anagrelide—Chest pain—Methotrexate—rheumatoid arthritis	0.000423	0.000443	CcSEcCtD
Anagrelide—Arthralgia—Methotrexate—rheumatoid arthritis	0.000423	0.000443	CcSEcCtD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—AHR—rheumatoid arthritis	0.000422	0.0094	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—rheumatoid arthritis	0.000422	0.0094	CbGpPWpGaD
Anagrelide—Decreased appetite—Prednisone—rheumatoid arthritis	0.000422	0.000442	CcSEcCtD
Anagrelide—Rash—Prednisolone—rheumatoid arthritis	0.000421	0.000441	CcSEcCtD
Anagrelide—Dermatitis—Prednisolone—rheumatoid arthritis	0.000421	0.00044	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.00042	0.00044	CcSEcCtD
Anagrelide—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000419	0.000439	CcSEcCtD
Anagrelide—Fatigue—Prednisone—rheumatoid arthritis	0.000418	0.000438	CcSEcCtD
Anagrelide—Headache—Prednisolone—rheumatoid arthritis	0.000418	0.000438	CcSEcCtD
Anagrelide—Discomfort—Methotrexate—rheumatoid arthritis	0.000418	0.000437	CcSEcCtD
Anagrelide—PDE3A—Hemostasis—PLEK—rheumatoid arthritis	0.000415	0.00926	CbGpPWpGaD
Anagrelide—Constipation—Prednisone—rheumatoid arthritis	0.000415	0.000434	CcSEcCtD
Anagrelide—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000415	0.000434	CcSEcCtD
Anagrelide—Rash—Hydrocortisone—rheumatoid arthritis	0.000411	0.00043	CcSEcCtD
Anagrelide—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000411	0.00043	CcSEcCtD
Anagrelide—Confusional state—Methotrexate—rheumatoid arthritis	0.000409	0.000428	CcSEcCtD
Anagrelide—Headache—Hydrocortisone—rheumatoid arthritis	0.000408	0.000428	CcSEcCtD
Anagrelide—Dizziness—Triamcinolone—rheumatoid arthritis	0.000406	0.000425	CcSEcCtD
Anagrelide—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000405	0.000424	CcSEcCtD
Anagrelide—Infection—Methotrexate—rheumatoid arthritis	0.000403	0.000422	CcSEcCtD
Anagrelide—Feeling abnormal—Prednisone—rheumatoid arthritis	0.0004	0.000419	CcSEcCtD
Anagrelide—Asthenia—Dexamethasone—rheumatoid arthritis	0.0004	0.000418	CcSEcCtD
Anagrelide—Asthenia—Betamethasone—rheumatoid arthritis	0.0004	0.000418	CcSEcCtD
Anagrelide—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000398	0.000416	CcSEcCtD
Anagrelide—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000397	0.000416	CcSEcCtD
Anagrelide—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000397	0.000415	CcSEcCtD
Anagrelide—Nausea—Prednisolone—rheumatoid arthritis	0.000397	0.000415	CcSEcCtD
Anagrelide—Pruritus—Dexamethasone—rheumatoid arthritis	0.000394	0.000413	CcSEcCtD
Anagrelide—Pruritus—Betamethasone—rheumatoid arthritis	0.000394	0.000413	CcSEcCtD
Anagrelide—Skin disorder—Methotrexate—rheumatoid arthritis	0.000394	0.000412	CcSEcCtD
Anagrelide—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000392	0.00041	CcSEcCtD
Anagrelide—Vomiting—Triamcinolone—rheumatoid arthritis	0.00039	0.000409	CcSEcCtD
Anagrelide—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000389	0.000408	CcSEcCtD
Anagrelide—Nausea—Hydrocortisone—rheumatoid arthritis	0.000387	0.000405	CcSEcCtD
Anagrelide—Rash—Triamcinolone—rheumatoid arthritis	0.000387	0.000405	CcSEcCtD
Anagrelide—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000387	0.000405	CcSEcCtD
Anagrelide—Anorexia—Methotrexate—rheumatoid arthritis	0.000386	0.000405	CcSEcCtD
Anagrelide—Rash—Methylprednisolone—rheumatoid arthritis	0.000386	0.000404	CcSEcCtD
Anagrelide—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000386	0.000404	CcSEcCtD
Anagrelide—Urticaria—Prednisone—rheumatoid arthritis	0.000385	0.000403	CcSEcCtD
Anagrelide—CYP1A2—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	0.000385	0.00857	CbGpPWpGaD
Anagrelide—Headache—Triamcinolone—rheumatoid arthritis	0.000385	0.000403	CcSEcCtD
Anagrelide—Headache—Methylprednisolone—rheumatoid arthritis	0.000384	0.000402	CcSEcCtD
Anagrelide—Abdominal pain—Prednisone—rheumatoid arthritis	0.000383	0.000401	CcSEcCtD
Anagrelide—Body temperature increased—Prednisone—rheumatoid arthritis	0.000383	0.000401	CcSEcCtD
Anagrelide—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000381	0.000399	CcSEcCtD
Anagrelide—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000381	0.000399	CcSEcCtD
Anagrelide—Hypotension—Methotrexate—rheumatoid arthritis	0.000379	0.000397	CcSEcCtD
Anagrelide—PDE3A—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.000379	0.00844	CbGpPWpGaD
Anagrelide—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000369	0.000387	CcSEcCtD
Anagrelide—Dizziness—Dexamethasone—rheumatoid arthritis	0.000368	0.000386	CcSEcCtD
Anagrelide—Dizziness—Betamethasone—rheumatoid arthritis	0.000368	0.000386	CcSEcCtD
Anagrelide—Insomnia—Methotrexate—rheumatoid arthritis	0.000367	0.000384	CcSEcCtD
Anagrelide—Nausea—Triamcinolone—rheumatoid arthritis	0.000365	0.000382	CcSEcCtD
Anagrelide—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000364	0.000381	CcSEcCtD
Anagrelide—Nausea—Methylprednisolone—rheumatoid arthritis	0.000364	0.000381	CcSEcCtD
Anagrelide—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000361	0.000378	CcSEcCtD
Anagrelide—PDE3A—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.000361	0.00805	CbGpPWpGaD
Anagrelide—Somnolence—Methotrexate—rheumatoid arthritis	0.00036	0.000377	CcSEcCtD
Anagrelide—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000357	0.000374	CcSEcCtD
Anagrelide—Vomiting—Betamethasone—rheumatoid arthritis	0.000354	0.000371	CcSEcCtD
Anagrelide—Vomiting—Dexamethasone—rheumatoid arthritis	0.000354	0.000371	CcSEcCtD
Anagrelide—PDE3A—G alpha (s) signalling events—POMC—rheumatoid arthritis	0.000353	0.00787	CbGpPWpGaD
Anagrelide—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000352	0.000369	CcSEcCtD
Anagrelide—Rash—Dexamethasone—rheumatoid arthritis	0.000351	0.000368	CcSEcCtD
Anagrelide—Rash—Betamethasone—rheumatoid arthritis	0.000351	0.000368	CcSEcCtD
Anagrelide—Dermatitis—Betamethasone—rheumatoid arthritis	0.000351	0.000367	CcSEcCtD
Anagrelide—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000351	0.000367	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.00035	0.000366	CcSEcCtD
Anagrelide—Fatigue—Methotrexate—rheumatoid arthritis	0.00035	0.000366	CcSEcCtD
Anagrelide—Headache—Dexamethasone—rheumatoid arthritis	0.000349	0.000365	CcSEcCtD
Anagrelide—Headache—Betamethasone—rheumatoid arthritis	0.000349	0.000365	CcSEcCtD
Anagrelide—Asthenia—Prednisone—rheumatoid arthritis	0.000348	0.000364	CcSEcCtD
Anagrelide—Pain—Methotrexate—rheumatoid arthritis	0.000347	0.000363	CcSEcCtD
Anagrelide—PDE3A—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.000344	0.00767	CbGpPWpGaD
Anagrelide—Pruritus—Prednisone—rheumatoid arthritis	0.000343	0.000359	CcSEcCtD
Anagrelide—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000334	0.00035	CcSEcCtD
Anagrelide—Diarrhoea—Prednisone—rheumatoid arthritis	0.000332	0.000348	CcSEcCtD
Anagrelide—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000332	0.000347	CcSEcCtD
Anagrelide—Nausea—Dexamethasone—rheumatoid arthritis	0.000331	0.000346	CcSEcCtD
Anagrelide—Nausea—Betamethasone—rheumatoid arthritis	0.000331	0.000346	CcSEcCtD
Anagrelide—PDE3A—Signaling by GPCR—CCL21—rheumatoid arthritis	0.000328	0.00731	CbGpPWpGaD
Anagrelide—Urticaria—Methotrexate—rheumatoid arthritis	0.000322	0.000337	CcSEcCtD
Anagrelide—Dizziness—Prednisone—rheumatoid arthritis	0.000321	0.000336	CcSEcCtD
Anagrelide—Body temperature increased—Methotrexate—rheumatoid arthritis	0.00032	0.000336	CcSEcCtD
Anagrelide—Abdominal pain—Methotrexate—rheumatoid arthritis	0.00032	0.000336	CcSEcCtD
Anagrelide—Vomiting—Prednisone—rheumatoid arthritis	0.000308	0.000323	CcSEcCtD
Anagrelide—Rash—Prednisone—rheumatoid arthritis	0.000306	0.00032	CcSEcCtD
Anagrelide—Dermatitis—Prednisone—rheumatoid arthritis	0.000306	0.00032	CcSEcCtD
Anagrelide—Headache—Prednisone—rheumatoid arthritis	0.000304	0.000318	CcSEcCtD
Anagrelide—PDE3A—Hemostasis—IL2RB—rheumatoid arthritis	0.000303	0.00675	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	0.000298	0.00665	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—SELE—rheumatoid arthritis	0.000293	0.00652	CbGpPWpGaD
Anagrelide—Asthenia—Methotrexate—rheumatoid arthritis	0.000291	0.000305	CcSEcCtD
Anagrelide—Nausea—Prednisone—rheumatoid arthritis	0.000288	0.000302	CcSEcCtD
Anagrelide—PDE3A—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.000287	0.0064	CbGpPWpGaD
Anagrelide—Pruritus—Methotrexate—rheumatoid arthritis	0.000287	0.0003	CcSEcCtD
Anagrelide—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000277	0.00029	CcSEcCtD
Anagrelide—PDE3A—Hemostasis—ITGAM—rheumatoid arthritis	0.000275	0.00613	CbGpPWpGaD
Anagrelide—Dizziness—Methotrexate—rheumatoid arthritis	0.000268	0.000281	CcSEcCtD
Anagrelide—PDE3A—Hemostasis—SH2B3—rheumatoid arthritis	0.000261	0.00581	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.000261	0.00581	CbGpPWpGaD
Anagrelide—Vomiting—Methotrexate—rheumatoid arthritis	0.000258	0.00027	CcSEcCtD
Anagrelide—Rash—Methotrexate—rheumatoid arthritis	0.000256	0.000268	CcSEcCtD
Anagrelide—Dermatitis—Methotrexate—rheumatoid arthritis	0.000255	0.000267	CcSEcCtD
Anagrelide—Headache—Methotrexate—rheumatoid arthritis	0.000254	0.000266	CcSEcCtD
Anagrelide—CYP1A2—Tryptophan metabolism—CAT—rheumatoid arthritis	0.000241	0.00538	CbGpPWpGaD
Anagrelide—Nausea—Methotrexate—rheumatoid arthritis	0.000241	0.000252	CcSEcCtD
Anagrelide—PDE3A—Hemostasis—GATA3—rheumatoid arthritis	0.000234	0.00522	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CXCL13—rheumatoid arthritis	0.000223	0.00498	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—TIMP1—rheumatoid arthritis	0.000222	0.00494	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CXCL6—rheumatoid arthritis	0.000203	0.00453	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.000203	0.00452	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—RASGRP1—rheumatoid arthritis	0.0002	0.00445	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—SYK—rheumatoid arthritis	0.000199	0.00443	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PRKCQ—rheumatoid arthritis	0.000195	0.00435	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCL21—rheumatoid arthritis	0.000194	0.00432	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SYVN1—rheumatoid arthritis	0.000194	0.00432	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.000192	0.00427	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000186	0.00414	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—C5—rheumatoid arthritis	0.000185	0.00412	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000181	0.00403	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.000174	0.00388	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.000174	0.00388	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—C5—rheumatoid arthritis	0.000168	0.00374	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PTK2—rheumatoid arthritis	0.000166	0.0037	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—NFKB1—rheumatoid arthritis	0.000161	0.00359	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—CSF2—rheumatoid arthritis	0.00016	0.00357	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.000159	0.00355	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000158	0.00352	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.000156	0.00347	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PDE2A—rheumatoid arthritis	0.000154	0.00343	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.000149	0.00331	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PLB1—rheumatoid arthritis	0.000147	0.00327	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—IL2RA—rheumatoid arthritis	0.000145	0.00322	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.000144	0.00322	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCL3—rheumatoid arthritis	0.000144	0.00322	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—SAA1—rheumatoid arthritis	0.000141	0.00315	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—MMP1—rheumatoid arthritis	0.000138	0.00307	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000136	0.00302	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000135	0.00301	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000135	0.00301	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—rheumatoid arthritis	0.000134	0.00299	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000134	0.00298	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	0.00013	0.0029	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—rheumatoid arthritis	0.000128	0.00286	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000126	0.00281	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—FN1—rheumatoid arthritis	0.000126	0.0028	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—NOS2—rheumatoid arthritis	0.000124	0.00277	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000123	0.00275	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.000123	0.00274	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.000123	0.00274	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000121	0.00271	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	0.00012	0.00268	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CXCL13—rheumatoid arthritis	0.00012	0.00267	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.00012	0.00266	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—rheumatoid arthritis	0.00012	0.00266	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—rheumatoid arthritis	0.000119	0.00265	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000115	0.00255	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000112	0.0025	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	0.000111	0.00248	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.000109	0.00242	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IRAK1—rheumatoid arthritis	0.000108	0.0024	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TLE3—rheumatoid arthritis	0.000108	0.0024	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000107	0.00238	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	0.000106	0.00235	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—ALB—rheumatoid arthritis	0.000105	0.00233	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000103	0.00229	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL2RB—rheumatoid arthritis	0.000103	0.00229	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.000101	0.00226	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	0.000101	0.00225	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—NOS3—rheumatoid arthritis	0.0001	0.00223	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—C5—rheumatoid arthritis	9.92e-05	0.00221	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	9.91e-05	0.00221	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—MMP3—rheumatoid arthritis	9.9e-05	0.00221	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NFATC1—rheumatoid arthritis	9.76e-05	0.00218	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCL5—rheumatoid arthritis	9.34e-05	0.00208	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCR6—rheumatoid arthritis	9.33e-05	0.00208	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—rheumatoid arthritis	9.29e-05	0.00207	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CCR5—rheumatoid arthritis	9.27e-05	0.00207	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CSF2—rheumatoid arthritis	9.2e-05	0.00205	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—IL2RA—rheumatoid arthritis	9.14e-05	0.00204	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NCF2—rheumatoid arthritis	9.08e-05	0.00202	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—C3—rheumatoid arthritis	9.06e-05	0.00202	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TRAF6—rheumatoid arthritis	8.85e-05	0.00197	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SH2B3—rheumatoid arthritis	8.85e-05	0.00197	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GZMB—rheumatoid arthritis	8.79e-05	0.00196	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	8.75e-05	0.00195	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	8.75e-05	0.00195	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	8.67e-05	0.00193	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—rheumatoid arthritis	8.67e-05	0.00193	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CXCL2—rheumatoid arthritis	8.53e-05	0.0019	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCL3—rheumatoid arthritis	8.53e-05	0.0019	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—IL2—rheumatoid arthritis	8.48e-05	0.00189	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCR5—rheumatoid arthritis	8.42e-05	0.00188	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SAA1—rheumatoid arthritis	8.35e-05	0.00186	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL2RA—rheumatoid arthritis	8.3e-05	0.00185	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—C3—rheumatoid arthritis	8.23e-05	0.00183	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NCF1—rheumatoid arthritis	8.17e-05	0.00182	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	8.14e-05	0.00181	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CD28—rheumatoid arthritis	7.86e-05	0.00175	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—UBE2D1—rheumatoid arthritis	7.4e-05	0.00165	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CXCL12—rheumatoid arthritis	7.26e-05	0.00162	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—BDKRB2—rheumatoid arthritis	7.26e-05	0.00162	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—POMC—rheumatoid arthritis	7.25e-05	0.00161	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—VEGFA—rheumatoid arthritis	7.2e-05	0.00161	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL6ST—rheumatoid arthritis	7.19e-05	0.0016	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ADRBK1—rheumatoid arthritis	7.17e-05	0.0016	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	7.14e-05	0.00159	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.77e-05	0.00151	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SYK—rheumatoid arthritis	6.75e-05	0.0015	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PRKCQ—rheumatoid arthritis	6.62e-05	0.00148	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—FADS2—rheumatoid arthritis	6.61e-05	0.00147	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—TGFB1—rheumatoid arthritis	6.61e-05	0.00147	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—POMC—rheumatoid arthritis	6.58e-05	0.00147	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—STAT1—rheumatoid arthritis	6.5e-05	0.00145	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCL2—rheumatoid arthritis	6.44e-05	0.00143	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL6R—rheumatoid arthritis	6.42e-05	0.00143	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CXCL10—rheumatoid arthritis	6.41e-05	0.00143	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MMP3—rheumatoid arthritis	5.85e-05	0.0013	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—TYK2—rheumatoid arthritis	5.85e-05	0.0013	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PTK2—rheumatoid arthritis	5.63e-05	0.00125	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—POMC—rheumatoid arthritis	5.61e-05	0.00125	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	5.6e-05	0.00125	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCL5—rheumatoid arthritis	5.52e-05	0.00123	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5.5e-05	0.00123	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—TP53—rheumatoid arthritis	5.44e-05	0.00121	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CSF2—rheumatoid arthritis	5.44e-05	0.00121	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—IL2—rheumatoid arthritis	5.36e-05	0.00119	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SPP1—rheumatoid arthritis	5.11e-05	0.00114	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.09e-05	0.00113	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCR5—rheumatoid arthritis	4.97e-05	0.00111	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL2RA—rheumatoid arthritis	4.9e-05	0.00109	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL2—rheumatoid arthritis	4.86e-05	0.00108	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—C3—rheumatoid arthritis	4.86e-05	0.00108	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—LEP—rheumatoid arthritis	4.52e-05	0.00101	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	4.41e-05	0.000984	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—FN1—rheumatoid arthritis	4.27e-05	0.000951	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	4.26e-05	0.00095	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL6ST—rheumatoid arthritis	4.25e-05	0.000947	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CD80—rheumatoid arthritis	4.09e-05	0.000912	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	4.01e-05	0.000893	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	3.9e-05	0.000869	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GC—rheumatoid arthritis	3.9e-05	0.000869	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—POMC—rheumatoid arthritis	3.89e-05	0.000866	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCL2—rheumatoid arthritis	3.8e-05	0.000848	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL6R—rheumatoid arthritis	3.79e-05	0.000845	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	3.62e-05	0.000808	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TYK2—rheumatoid arthritis	3.45e-05	0.00077	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NOS3—rheumatoid arthritis	3.39e-05	0.000755	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MED1—rheumatoid arthritis	3.18e-05	0.000708	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CXCL8—rheumatoid arthritis	3.01e-05	0.00067	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	2.95e-05	0.000658	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	2.95e-05	0.000658	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL2—rheumatoid arthritis	2.87e-05	0.00064	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL6—rheumatoid arthritis	2.86e-05	0.000637	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MMP9—rheumatoid arthritis	2.72e-05	0.000606	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NFKB1—rheumatoid arthritis	2.69e-05	0.0006	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—BGN—rheumatoid arthritis	2.66e-05	0.000593	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MAPK8—rheumatoid arthritis	2.64e-05	0.000589	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	2.45e-05	0.000546	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.44e-05	0.000544	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.24e-05	0.0005	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.15e-05	0.00048	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	2e-05	0.000445	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.96e-05	0.000437	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TP53—rheumatoid arthritis	1.85e-05	0.000411	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.72e-05	0.000383	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL6—rheumatoid arthritis	1.69e-05	0.000376	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.44e-05	0.00032	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.2e-05	0.000267	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—POMC—rheumatoid arthritis	9.59e-06	0.000214	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ALB—rheumatoid arthritis	8.74e-06	0.000195	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	8.36e-06	0.000186	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	7.65e-06	0.00017	CbGpPWpGaD
